APA (7th ed.) Citation

Alonso, A., Morris, A. A., Naimi, A. I., Alam, A. B., Li, L., Subramanya, V., . . . Lutsey, P. L. (2024, March). Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Angiotensin Receptor‐Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real‐World Data. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Chicago Style (17th ed.) Citation

Alonso, Alvaro, Alanna A. Morris, Ashley I. Naimi, Aniqa B. Alam, Linzi Li, Vinita Subramanya, Lin Yee Chen, and Pamela L. Lutsey. "Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Angiotensin Receptor‐Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real‐World Data." Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease Mar. 2024.

MLA (9th ed.) Citation

Alonso, Alvaro, et al. "Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Angiotensin Receptor‐Neprilysin Inhibitors in Patients With Atrial Fibrillation and Heart Failure From 2021 to 2022: An Analysis of Real‐World Data." Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Mar. 2024.